Solventum Corporation (SOLV)
NYSE · Healthcare
Solventum Corporation EBITDA 2022–2025
Solventum Corporation annual/quarterly ebitda history and growth rate from 2022 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Solventum Corporation ebitda for the quarter ending March 31, 2026 was 216.0 M, a 23.13% decrease year-over-year.
- Solventum Corporation ebitda for the twelve months ending March 31, 2026 was 1.5 B.
- Solventum Corporation annual ebitda for 2025 was 2.7 B, a 67.82% increase from 2024.
- Solventum Corporation annual ebitda for 2024 was 1.6 B, a 29.38% decrease from 2023.
- Solventum Corporation annual ebitda for 2023 was 2.3 B, a 0.79% decrease from 2022.
- Solventum Corporation annual ebitda for 2022 was 2.3 B.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
Solventum Corporation EBITDA — FAQ
Solventum Corporation (SOLV) ebitda over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SOLV's ebitda history?
The chart and table above show Solventum Corporation's ebitda by year and by quarter, including the growth rate.